Compare WHF & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHF | PROF |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.2M | 189.2M |
| IPO Year | 2012 | N/A |
| Metric | WHF | PROF |
|---|---|---|
| Price | $7.71 | $6.64 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.75 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 185.0K | 99.4K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | ★ 23.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $76,339,000.00 | $14,297,000.00 |
| Revenue This Year | N/A | $64.23 |
| Revenue Next Year | N/A | $113.06 |
| P/E Ratio | $17.92 | ★ N/A |
| Revenue Growth | N/A | ★ 67.94 |
| 52 Week Low | $6.39 | $3.76 |
| 52 Week High | $11.31 | $8.75 |
| Indicator | WHF | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 63.20 | 55.13 |
| Support Level | $7.16 | $6.09 |
| Resistance Level | $7.34 | $7.04 |
| Average True Range (ATR) | 0.21 | 0.42 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 89.19 | 61.00 |
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.